vs
Side-by-side financial comparison of Dayforce (DAY) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $481.6M, roughly 1.0× Dayforce). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs -40.9%, a 47.7% gap on every dollar of revenue. On growth, Dayforce posted the faster year-over-year revenue change (9.5% vs -1.7%). Over the past eight quarters, Dayforce's revenue compounded faster (9.8% CAGR vs -0.1%).
Dayforce, Inc., formerly Ceridian, is an American human resources software and services company.
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
DAY vs MD — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $481.6M | $493.8M |
| Net Profit | $-196.8M | $33.7M |
| Gross Margin | — | — |
| Operating Margin | 6.3% | 9.9% |
| Net Margin | -40.9% | 6.8% |
| Revenue YoY | 9.5% | -1.7% |
| Net Profit YoY | -9940.0% | 10.5% |
| EPS (diluted) | $-1.23 | $0.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $493.8M | ||
| Q3 25 | $481.6M | $492.9M | ||
| Q2 25 | $464.7M | $468.8M | ||
| Q1 25 | $481.8M | $458.4M | ||
| Q4 24 | $465.2M | $502.4M | ||
| Q3 24 | $440.0M | $511.2M | ||
| Q2 24 | $423.3M | $504.3M | ||
| Q1 24 | $431.5M | $495.1M |
| Q4 25 | — | $33.7M | ||
| Q3 25 | $-196.8M | $71.7M | ||
| Q2 25 | $21.3M | $39.3M | ||
| Q1 25 | $14.9M | $20.7M | ||
| Q4 24 | $10.8M | $30.5M | ||
| Q3 24 | $2.0M | $19.4M | ||
| Q2 24 | $-1.8M | $-153.0M | ||
| Q1 24 | $7.1M | $4.0M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 47.0% | — | ||
| Q3 24 | 45.8% | — | ||
| Q2 24 | 44.1% | — | ||
| Q1 24 | 47.6% | — |
| Q4 25 | — | 9.9% | ||
| Q3 25 | 6.3% | 13.8% | ||
| Q2 25 | 9.1% | 12.8% | ||
| Q1 25 | 6.4% | 7.0% | ||
| Q4 24 | 6.1% | 7.8% | ||
| Q3 24 | 4.7% | 6.6% | ||
| Q2 24 | 3.3% | -31.3% | ||
| Q1 24 | 9.4% | 3.2% |
| Q4 25 | — | 6.8% | ||
| Q3 25 | -40.9% | 14.5% | ||
| Q2 25 | 4.6% | 8.4% | ||
| Q1 25 | 3.1% | 4.5% | ||
| Q4 24 | 2.3% | 6.1% | ||
| Q3 24 | 0.5% | 3.8% | ||
| Q2 24 | -0.4% | -30.3% | ||
| Q1 24 | 1.6% | 0.8% |
| Q4 25 | — | $0.40 | ||
| Q3 25 | $-1.23 | $0.84 | ||
| Q2 25 | $0.13 | $0.46 | ||
| Q1 25 | $0.09 | $0.24 | ||
| Q4 24 | $0.07 | $0.37 | ||
| Q3 24 | $0.01 | $0.23 | ||
| Q2 24 | $-0.01 | $-1.84 | ||
| Q1 24 | $0.04 | $0.05 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $627.6M | $375.2M |
| Total DebtLower is stronger | $631.1M | $570.5M |
| Stockholders' EquityBook value | $2.7B | $865.9M |
| Total Assets | $8.7B | $2.2B |
| Debt / EquityLower = less leverage | 0.23× | 0.66× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $375.2M | ||
| Q3 25 | $627.6M | $340.1M | ||
| Q2 25 | $625.2M | $224.7M | ||
| Q1 25 | $557.3M | $99.0M | ||
| Q4 24 | $579.7M | $229.9M | ||
| Q3 24 | $494.1M | $103.8M | ||
| Q2 24 | $465.4M | $19.4M | ||
| Q1 24 | $392.5M | $8.0M |
| Q4 25 | — | $570.5M | ||
| Q3 25 | $631.1M | $577.2M | ||
| Q2 25 | $631.8M | $583.9M | ||
| Q1 25 | $632.4M | $590.5M | ||
| Q4 24 | $1.2B | $597.1M | ||
| Q3 24 | $1.2B | — | ||
| Q2 24 | $1.2B | — | ||
| Q1 24 | $1.2B | — |
| Q4 25 | — | $865.9M | ||
| Q3 25 | $2.7B | $890.7M | ||
| Q2 25 | $2.7B | $833.8M | ||
| Q1 25 | $2.6B | $789.2M | ||
| Q4 24 | $2.5B | $764.9M | ||
| Q3 24 | $2.6B | $732.5M | ||
| Q2 24 | $2.5B | $706.5M | ||
| Q1 24 | $2.4B | $856.2M |
| Q4 25 | — | $2.2B | ||
| Q3 25 | $8.7B | $2.2B | ||
| Q2 25 | $8.5B | $2.1B | ||
| Q1 25 | $9.5B | $2.0B | ||
| Q4 24 | $9.1B | $2.2B | ||
| Q3 24 | $8.1B | $2.1B | ||
| Q2 24 | $9.0B | $2.0B | ||
| Q1 24 | $10.8B | $2.2B |
| Q4 25 | — | 0.66× | ||
| Q3 25 | 0.23× | 0.65× | ||
| Q2 25 | 0.23× | 0.70× | ||
| Q1 25 | 0.24× | 0.75× | ||
| Q4 24 | 0.47× | 0.78× | ||
| Q3 24 | 0.47× | — | ||
| Q2 24 | 0.49× | — | ||
| Q1 24 | 0.50× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $31.2M | $114.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.39× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $114.1M | ||
| Q3 25 | $31.2M | $137.3M | ||
| Q2 25 | $112.7M | $137.2M | ||
| Q1 25 | $49.6M | $-117.5M | ||
| Q4 24 | $81.0M | $133.0M | ||
| Q3 24 | $91.8M | $91.8M | ||
| Q2 24 | $99.2M | $107.0M | ||
| Q1 24 | $9.1M | $-125.2M |
| Q4 25 | — | 3.39× | ||
| Q3 25 | — | 1.91× | ||
| Q2 25 | 5.29× | 3.49× | ||
| Q1 25 | 3.33× | -5.66× | ||
| Q4 24 | 7.50× | 4.36× | ||
| Q3 24 | 45.90× | 4.72× | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.28× | -31.03× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DAY
| Dayforce Recurring | $333.0M | 69% |
| Cloud And Bureau Professional Services And Other | $78.5M | 16% |
| Float | $42.2M | 9% |
| Powerpay Recurring | $19.7M | 4% |
| Other Recurring | $8.2M | 2% |
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
